New DMSO combo therapy targets ringing ears in Long-COVID patients
NCT ID NCT07567274
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests a compounded DMSO-based ear drops and cream for adults with bothersome tinnitus linked to long-COVID or post-COVID-19 vaccine injury. Twenty participants who have not improved with at least two prior treatments will use the ear drops every 4 days and apply the cream daily for 30 days. The main goal is to see if at least half of them experience a 50% or greater reduction in tinnitus-related handicap, with follow-up over 12 months via telemedicine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SUBJECTIVE TINNITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nationwide Telemedicine Study (Leading Edge Clinic)
Ithaca, New York, 14851, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a patch behind the ear silence tinnitus?
- Could your hearing aid silence the ringing? new study tests built-in tinnitus relief
- Touch and tingle: Non-Invasive therapies take on ringing ears
- Can acupuncture silence the ringing? new trial puts it to the test
- Could an Outer-Ear implant silence ringing that Won't stop?
- Can sound or talk therapy silence the ringing in your ears?